Lb Pharmaceuticals LBRX
NASDAQ LBRX
$37.20 -0.08 (-0.21%)
As of: Oct 2, 2026 · 10:34 AM EDT

Lb Pharmaceuticals (LBRX) Net Equity Issued and Repurchased (2025 - 2026)

Updated

Lb Pharmaceuticals' Net Equity Issued and Repurchased came in at $100 million for Q1 2026.

Analysis

Lb Pharmaceuticals (LBRX) Net Equity Issued and Repurchased (2025 - 2026) Analysis & Trends

For FY2025, Lb Pharmaceuticals' Net Equity Issued and Repurchased was $327.75 million, up 719.4% from FY2024.

  • Going back by year, Net Equity Issued and Repurchased was $40 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Lb Pharmaceuticals 1.10 Bn 1.10 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 100.00 Mn
Sep 30, 2025 327.75 Mn
API Access

Lb Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LBRX&period=max&api_key=YOUR_API_KEY